Incannex Healthcare Inc. (IXHL)
NASDAQ: IXHL · Real-Time Price · USD
4.240
+0.340 (8.72%)
Mar 9, 2026, 3:43 PM EDT - Market open
Incannex Healthcare Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Operating Revenue | - | 0.09 | 0.01 | - | - | 1.42 | Upgrade
|
| Other Revenue | - | - | - | - | 0.54 | 0 | Upgrade
|
| Revenue | - | 0.09 | 0.01 | - | 0.54 | 1.42 | Upgrade
|
| Revenue Growth (YoY) | - | 616.67% | - | - | -62.11% | 240.67% | Upgrade
|
| Cost of Revenue | - | - | - | - | 0 | 0.68 | Upgrade
|
| Gross Profit | - | 0.09 | 0.01 | - | 0.53 | 0.74 | Upgrade
|
| Selling, General & Admin | 16.48 | 13.13 | 17.17 | 8.01 | 3.55 | 4.39 | Upgrade
|
| Research & Development | 8.98 | 8.99 | 1.45 | 5.63 | 3.7 | 3.56 | Upgrade
|
| Other Operating Expenses | - | - | - | - | - | -0.03 | Upgrade
|
| Operating Expenses | 25.46 | 22.12 | 18.62 | 13.64 | 8.36 | 8.38 | Upgrade
|
| Operating Income | -25.46 | -22.03 | -18.61 | -13.64 | -7.82 | -7.64 | Upgrade
|
| Interest Expense | -0.13 | -0.3 | - | - | - | - | Upgrade
|
| Interest & Investment Income | 0.02 | 0.06 | 0.21 | 0.24 | 0 | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.01 | -0.29 | -0.03 | -0.07 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -21.47 | -22.85 | - | - | -2.45 | -0.89 | Upgrade
|
| EBT Excluding Unusual Items | -47.03 | -45.41 | -18.43 | -13.46 | -10.27 | -8.53 | Upgrade
|
| Other Unusual Items | -1.47 | -1.47 | - | - | - | - | Upgrade
|
| Pretax Income | -48.5 | -46.89 | -18.43 | -48.81 | -10.27 | -8.53 | Upgrade
|
| Income Tax Expense | - | - | 0.03 | - | - | - | Upgrade
|
| Earnings From Continuing Operations | -48.5 | -46.89 | -18.46 | -48.81 | -10.27 | -8.53 | Upgrade
|
| Net Income | -48.5 | -46.89 | -18.46 | -48.81 | -10.27 | -8.53 | Upgrade
|
| Net Income to Common | -48.5 | -46.89 | -18.46 | -48.81 | -10.27 | -8.53 | Upgrade
|
| Shares Outstanding (Basic) | 6 | 1 | 1 | 1 | 10 | 8 | Upgrade
|
| Shares Outstanding (Diluted) | 6 | 1 | 1 | 1 | 10 | 8 | Upgrade
|
| Shares Change (YoY) | 1020.94% | 113.15% | 5.07% | -94.83% | 21.93% | 42.82% | Upgrade
|
| EPS (Basic) | -7.63 | -40.82 | -34.26 | -95.18 | -1.03 | -1.05 | Upgrade
|
| EPS (Diluted) | -7.63 | -40.82 | -34.26 | -95.18 | -1.03 | -1.05 | Upgrade
|
| Free Cash Flow | -18.43 | -12.52 | -16.12 | -11.07 | -8.82 | -5.18 | Upgrade
|
| Free Cash Flow Per Share | -2.90 | -10.90 | -29.92 | -21.58 | -0.89 | -0.64 | Upgrade
|
| Gross Margin | - | 100.00% | 100.00% | - | 99.19% | 51.94% | Upgrade
|
| Operating Margin | - | -25619.77% | -155058.33% | - | -1450.78% | -536.77% | Upgrade
|
| Profit Margin | - | -54517.44% | -153825.00% | - | -1904.94% | -599.33% | Upgrade
|
| Free Cash Flow Margin | - | -14559.30% | -134350.00% | - | -1636.97% | -364.13% | Upgrade
|
| EBITDA | -25.38 | -21.89 | -18.5 | -13.62 | - | - | Upgrade
|
| D&A For EBITDA | 0.08 | 0.14 | 0.1 | 0.02 | - | - | Upgrade
|
| EBIT | -25.46 | -22.03 | -18.61 | -13.64 | -7.82 | -7.64 | Upgrade
|
| Revenue as Reported | - | - | - | - | - | 1.48 | Upgrade
|
| Advertising Expenses | - | - | - | - | 1.89 | 3.26 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.